- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06937684
Early Oral Fluid Intake in Children After Day Surgery
Oral Fluid Timing and Volume in Children Aged 1-8 Following Ambulatory Surgery: A Prospective Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective, randomized controlled clinical trial aims to evaluate the safety and tolerability of early oral clear fluid intake in children aged 1 to 8 years undergoing elective, outpatient, non-gastrointestinal surgery under general anesthesia. Recent guidelines recommend reducing preoperative and postoperative fasting durations in children to enhance recovery and well-being. Early postoperative hydration has been associated with reduced opioid requirements, faster return to normal diet and ambulation, and shorter hospital stay, without increasing the risk of postoperative nausea and vomiting (PONV).
In this study, participants will be randomly assigned to one of two groups. Group E (early group) will receive up to 10 ml/kg of clear fluids (e.g., water, clear juice) one hour after the end of anesthesia, while Group T (traditional group) will receive the same amount two hours after anesthesia. Patients will be evaluated for readiness to drink based on recovery of consciousness, protective airway reflexes, and absence of nausea or vomiting. Fluid will be administered slowly and under strict supervision by experienced staff, with emergency equipment readily available.
The incidence of vomiting will be assessed using a modified 4-point scale. Additional outcome measures include tolerability of oral fluids, time to readiness for discharge, and incidence of delayed postoperative vomiting on postoperative days 1 and 3, assessed via phone interviews with caregivers. This study seeks to provide evidence-based guidance on the optimal timing and volume of clear fluid intake in pediatric patients following ambulatory minor surgical procedures, contributing to more flexible and patient-centered perioperative fasting protocols.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey (Türkiye), 06800
- Ankara City Hospital Bilkent
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children aged between 1 and 8 years
- ASA Physical Status I or II
- Undergoing elective, outpatient, non-gastrointestinal surgery under general anesthesia
- Expected to be discharged on the same day
- Parent/guardian provides informed consent
Exclusion Criteria:
- Emergency surgeries
- History of gastrointestinal disorders
- History of aspiration or recurrent vomiting
- Children with neurodevelopmental delay
- Intraoperative complications requiring ICU admission
- Refusal of oral intake postoperatively
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Early Oral Intake Group (Group E)
Patients in this group will receive a maximum of 10 ml/kg of clear fluids (e.g., water or clear fruit juice) starting at 1 hour after the completion of general anesthesia.
|
Participants receive clear fluids up to 10 ml/kg at 1 hour after anesthesia.
|
|
Active Comparator: Traditional Oral Intake Group (Group T)
Patients in this group will receive a maximum of 10 ml/kg of clear fluids (e.g., water or clear fruit juice) starting at 2 hours after the completion of general anesthesia.
|
Participants receive clear fluids up to 10 ml/kg at 2 hours after anesthesia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tolerability of Early Oral Clear Fluid Intake in Children
Time Frame: From end of anesthesia to discharge (approximately 3-4 hours postoperative)
|
The number of pediatric participants who are able to tolerate clear oral fluids (up to 10 ml/kg) administered 1 hour after general anesthesia without experiencing vomiting, desaturation (SpO₂ < 94%), or other adverse events.
Tolerability is defined as successful ingestion of the planned fluid volume without signs of intolerance such as nausea, vomiting, or clinical deterioration.
|
From end of anesthesia to discharge (approximately 3-4 hours postoperative)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Volume of Oral Fluids Tolerated
Time Frame: Within 1 and 2 hours post-anesthesia
|
Amount of oral clear fluid (in ml/kg) successfully consumed by participants during the initial postoperative oral hydration attempt.
|
Within 1 and 2 hours post-anesthesia
|
|
Incidence of Postoperative Vomiting
Time Frame: From end of anesthesia to discharge (within approximately 4 hours)
|
Number of participants who experience vomiting after receiving oral clear fluids, as assessed using a 4-point modified vomiting scale from anesthesia end until discharge.
|
From end of anesthesia to discharge (within approximately 4 hours)
|
|
Incidence of Postoperative Vomiting on Day 1 and Day 3
Time Frame: Postoperative day 1 and day 3
|
Number of participants with parent-reported postoperative nausea assessed via structured telephone interviews conducted on postoperative day 1 and day 3.
|
Postoperative day 1 and day 3
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Feyza Sever, Assoc Prof, Ankara City Hospital Bilkent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E2-24-6970
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Anesthesia
-
Children's Hospital of PhiladelphiaErasmus Medical Center; University of Texas Southwestern Medical Center; Children... and other collaboratorsCompletedPediatric Anesthesia | General Anesthesia | ElectroencephalographyUnited States, Australia, Switzerland, China, Netherlands
-
Gødstrup HospitalAarhus University HospitalRecruitingPediatric Anesthesia | PROMs | Pediatric Surgery | PREMsDenmark
-
Bozok UniversityEnrolling by invitationPediatric AnesthesiaTurkey
-
Bürgerhospital FrankfurtCompleted
-
Baylor College of MedicineRecruitingPediatric AnesthesiaUnited States
-
Wake Forest University Health SciencesCompleted
-
Tanta UniversityCompleted
-
Istanbul University - CerrahpasaNot yet recruitingPediatric Anesthesia | Pediatric Postoperative Recovery | Pediatric Enhanced Recovery After SurgeryTurkey (Türkiye)
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingPediatric Anesthesia | Airway Management | General Anesthesia | LMAChina
-
Centre Hospitalier Universitaire Saint PierreUnknownAnesthesia | Pediatric CircumcisionBelgium
Clinical Trials on Early Oral Fluid Intake
-
Peking Union Medical College HospitalNot yet recruiting
-
Xuzhou Medical UniversityThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...UnknownPancreaticoduodenectomy | Periampullary Carcinoma ResectableChina
-
Medical University of ViennaCompleted
-
Poitiers University HospitalCompletedScheduled General Anaesthesia With Airway ControlFrance
-
Peking Union Medical College HospitalCompleted
-
University Children's Hospital BaselSwiss Neonatal Network; SwissPedNetRecruitingBronchopulmonary DysplasiaSwitzerland
-
Regional Hospital HolstebroCompletedChronic Kidney Diseases | Polycystic Kidney, Autosomal DominantDenmark
-
Region StockholmCapio Sankt Görans Hospital; Ersta Hospital, SwedenRecruiting
-
Wake Forest University Health SciencesDanone ResearchCompletedWeight GainUnited States
-
PepsiCo Global R&DCompleted